The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York DIHEXA Research Capsules Peptide Tech Everything You Need to Know About the FDA Peptide Ban Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding.